The Brighton declaration: the value of non-communicable disease modelling in population health sciences

European Journal of Epidemiology

Volumn 29, Issue 12, 2014, Pages 867-870

  Webber, Laura ^a   Mytton, Oliver T ^b   Briggs, Adam D M ^c   Woodcock, James ^b   Scarborough, Peter ^c   McPherson, Klim ^c   Capewell, Simon ^d  

^a UK Health Forum   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DISEASE MODEL; EDITORIAL; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; NON COMMUNICABLE DISEASE; PRACTICE GUIDELINE; PUBLIC HEALTH; STANDARDIZATION; UNITED KINGDOM; COMMUNICABLE DISEASES; COMPUTER SIMULATION; HEALTH; THEORETICAL MODEL;

COMMUNICABLE DISEASES; COMPUTER SIMULATION; GLOBAL HEALTH; HUMANS; MODELS, THEORETICAL;

EID: 84925501660     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9978-0     Document Type: Editorial

References (21)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al. Global and regional mortality from 235 causes of death for 20 age groups in, 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.
2. Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 2009;27:533–45.
3. Astolfi R, Lorenzoni L, Oderkirk J. Informing policy makers about future health spending: a comparative analysis of forecasting methods in OECD countries. Health Policy. 2012;107:1–10.
4. Barhak J, Isaman DJM, Ye W, Lee D. Chronic disease modeling and simulation software. J Biomed Inform. 2010;43:791–9.
5. Kopec JA, Sayre EC, Flanagan WM, Fines P, Cibere J, Rahman MM, Bansback NJ, Anis AH, Jordan JM, Sobolev B, Aghajanian J, Kang W, Greidanus NV, Garbuz DS, Hawker GA, Badley EM. Development of a population-based microsimulation model of osteoarthritis in Canada. Osteoarthr Cartil. 2010;18:303–11.
6. Unal B, Capewell S, Critchley JA. Coronary heart disease policy models: a systematic review. BMC Public Health. 2006;6:213.
7. Maglio PP, Mabry PL. Agent-based models and systems science approaches to public health. Am J Prev Med. 2011;40:392–4.
8. World Health Organization. The Ottawa charter for health promotion. Geneva. 1986.
9. Purshouse RC, Meier PS, Brennan A, Taylor KB, Rafia R. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet. 2010;375:1355–64.
10. Jarrett J, Woodcock J, Griffiths UK, Chalabi Z, Edwards P, Roberts I, Haines A. Effect of increasing active travel in urban England and wales on costs to the National Health Service. Lancet. 2012;379:2198–205.
11. Kahlmeier S, Racioppi F, Cavill N, Rutter H, Oja P. “Health in all policies” in practice: guidance and tools to quantifying the health effects of cycling and walking. J Phys Act Health. 2010;7(Suppl 1):S120–5.
12. Cobiac LJ, Magnus A, Lim S, Barendregt JJ, Carter R, Vos T. Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS ONE. 2012;7:e41842.
13. McPherson K, Marsh T, Brown M. Foresight. Tackling obesities: future choices—modelling future trends in obesity and the impact on health. 2nd ed. London: Government Office for Science; 2007.
14. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–40.
15. Pharoah PDP, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost effectiveness of the NHS breast screening programme: life table model. BMJ. 2013;346:f2618.
16. Woodcock J, Tainio M, Cheshire J, O’Brien O, Goodman A. Health effects of the London bicycle sharing system: health impact modelling study. BMJ. 2014;348:g425.
17. Kopec JA, Finès P, Manuel DG, Buckeridge DL, Flanagan WM, Oderkirk J, Abrahamowicz M, Harper S, Sharif B, Okhmatovskaia A, Sayre EC, Rahman MM, Wolfson MC. Validation of population-based disease simulation models: a review of concepts and methods. BMC Public Health. 2010;10:710.
18. Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices-modeling studies. Value Health. 2003;6:9–17.
19. Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004, 8: iii–iv, ix–xi: 1–158.
20. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ. 2013;346:f1049.
21. Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices—overview: a report of the ISPOR-SMDM modeling good research practices task force–1. Value Health. 2012;15:796–803.